Depletion of spleen macrophages delays AA amyloid development: A study performed in the rapid mouse model of aa amyloidosis

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Lundmark, Katarzyna ^a   Shariatpanahi, Aida Vahdat ^a   Westermark, Gunilla T ^b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID ENHANCING FACTOR; CLODRONIC ACID; ENZYME; LIPOSOME; SILVER NITRATE; UNCLASSIFIED DRUG;

AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; FEMALE; MACROPHAGE; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION; MARGINAL ZONE MACROPHAGE; METALLOPHILIC MARGINAL ZONE MACROPHAGE; MOUSE; NONHUMAN; RED PULP MACROPHAGE; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; SPLEEN CELL;

AMYLOIDOSIS; ANIMALS; ANIMALS, OUTBRED STRAINS; FEMALE; HUMANS; MACROPHAGES; MICE; SERUM AMYLOID A PROTEIN; SPLEEN;

EID: 84893374758     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079104     Document Type: Article

References (44)

1. Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, et al. (2012) Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 19: 167-170.
2. Ein D, Kimura S, Terry WD, Magnotta J, Glenner GG (1972) Amino acid sequence of an amyloid fibril protein of unknown origin. The Journal of biological chemistry 247: 5653-5655.
3. Westermark GT, Westermark P, Sletten K (1987) Amyloid fibril protein AA. Characterization of uncommon subspecies from a patient with rheumatoid arthritis. Laboratory investigation; a journal of technical methods and pathology 57: 57-64.
4. Benditt EP, Eriksen N, Hanson RH (1979) Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein. Proceedings of the National Academy of Sciences of the United States of America 76: 4092-4096.
5. Malle E, Steinmetz A, Raynes JG (1993) Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 102: 131-146.
6. Steel DM, Rogers JT, DeBeer MC, DeBeer FC, Whitehead AS (1993) Biosynthesis of human acute-phase serum amyloid A protein (A-SAA) in vitro: the roles of mRNA accumulation, poly(A) tail shortening and translational efficiency. The Biochemical journal 291 (Pt 3): 701-707.
7. Takahashi M, Yokota T, Kawano H, Gondo T, Ishihara T, et al. (1989) Ultrastructural evidence for intracellular formation of amyloid fibrils in macrophages. Virchows Archiv A, Pathological anatomy and histopathology 415: 411-419.
8. Chronopoulos S, Laird DW, Ali-Khan Z (1994) Immunolocalization of serum amyloid A and AA amyloid in lysosomes in murine monocytoid cells: confocal and immunogold electron microscopic studies. The Journal of pathology 173: 361-369.
9. Magy N, Benson MD, Liepnieks JJ, Kluve-Beckerman B (2007) Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model. Amyloid: the international journal of experimental and clinical investigation: the official journal of the International Society of Amyloidosis 14: 51-63.
10. Olsen KE, Sletten K, Sandgren O, Olsson H, Myrvold K, et al. (1999) What is the role of giant cells in AL-amyloidosis? Amyloid: the international journal of experimental and clinical investigation: the official journal of the International Society of Amyloidosis 6: 89-97.
11. Bodin K, Ellmerich S, Kahan MC, Tennent GA, Loesch A, et al. (2010) Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. Nature 468: 93-97.
12. Nystrom SN, Westermark GT (2012) AA-Amyloid is cleared by endogenous immunological mechanisms. Amyloid 19: 138-145.
13. Boissonneault V, Filali M, Lessard M, Relton J, Wong G, et al. (2009) Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Brain: a journal of neurology 132: 1078-1092.
14. Harper JD, Lansbury PT, Jr. (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annual review of biochemistry 66: 385-407.
15. Mishra R, Sorgjerd K, Nystrom S, Nordigarden A, Yu YC, et al. (2007) Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion. Journal of molecular biology 366: 1029-1044.
16. Giurleo JT, He X, Talaga DS (2008) Beta-lactoglobulin assembles into amyloid through sequential aggregated intermediates. Journal of molecular biology 381: 1332-1348.
17. Kisilevsky R, Boudreau L (1983) Kinetics of amyloid deposition. I. The effects of amyloid-enhancing factor and splenectomy. Laboratory investigation; a journal of technical methods and pathology 48: 53-59.
18. Niewold TA, Gruys E, Arakawa T, Shirahama T, Kisilevsky R (1993) Recombinant human tumour necrosis factor-alpha (rhTNF-alpha) and rhTNF-alpha analogue enhance amyloid deposition in the Syrian hamster. Scandinavian journal of immunology 37: 29-32.
19. Sorby R, Espenes A, Landsverk T, Westermark G (2008) Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor. Amyloid: the international journal of experimental and clinical investigation: the official journal of the International Society of Amyloidosis 15: 20-28.
20. Ganowiak K, Hultman P, Engstrom U, Gustavsson A, Westermark P (1994) Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice. Biochemical and biophysical research communications 199: 306-312.
21. Kisilevsky R (2005) Preparation and propagation of amyloid-enhancing factor. Methods in molecular biology 299: 237-241.
22. Steiniger B, Barth P (2000) Microanatomy and function of the spleen. Advances in anatomy, embryology, and cell biology 151: III-IX, 1-101.
23. Kraal G (1992) Cells in the marginal zone of the spleen. International review of cytology 132: 31-74.
24. Geijtenbeek TB, Groot PC, Nolte MA, van Vliet SJ, Gangaram-Panday ST, et al. (2002) Marginal zone macrophages express a murine homologue of DCSIGN that captures blood-borne antigens in vivo. Blood 100: 2908-2916.
25. Kraal G, Janse M (1986) Marginal metallophilic cells of the mouse spleen identified by a monoclonal antibody. Immunology 58: 665-669.
26. Austyn JM, Gordon S (1981) F4/80, a monoclonal antibody directed specifically against the mouse macrophage. European journal of immunology 11: 805-815.
27. Lundmark K, Westermark GT, Nystrom S, Murphy CL, Solomon A, et al. (2002) Transmissibility of systemic amyloidosis by a prion-like mechanism. Proceedings of the National Academy of Sciences of the United States of America 99: 6979-6984.
28. Kluve-Beckerman B, Manaloor JJ, Liepnieks JJ (2002) A pulse-chase study tracking the conversion of macrophage-endocytosed serum amyloid A into extracellular amyloid. Arthritis and rheumatism 46: 1905-1913.
29. Sponarova J, Nuvolone M, Whicher C, Frei N, Kana V, et al. (2013) Efficient amyloid a clearance in the absence of immunoglobulins and complement factors. The American journal of pathology 182: 1297-1307.
30. Jablonska J, Dittmar KE, Kleinke T, Buer J, Weiss S (2007) Essential role of CCL2 in clustering of splenic ERTR-9+ macrophages during infection of BALB/c mice by Listeria monocytogenes. Infection and immunity 75: 462-470.
31. Groom AC, Schmidt EE, MacDonald IC (1991) Microcirculatory pathways and blood flow in spleen: new insights from washout kinetics, corrosion casts, and quantitative intravital videomicroscopy. Scanning microscopy 5: 159-173; discussion 173-154.
32. Kang YS, Kim JY, Bruening SA, Pack M, Charalambous A, et al. (2004) The Ctype lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen. Proceedings of the National Academy of Sciences of the United States of America 101: 215-220.
33. Shirahama T, Cohen AS (1971) Lysosomal breakdown of amyloid fibrils by macrophages. The American journal of pathology 63: 463-486.
34. van Rooijen N (1992) Liposomes as an in vivo tool to study and manipulate macrophage function. Research in immunology 143: 177-178.
35. Rogers MJ, Crockett JC, Coxon FP, Monkkonen J (2011) Biochemical and molecular mechanisms of action of bisphosphonates. Bone 49: 34-41.
36. Buiting AM, Zhou F, Bakker JA, van Rooijen N, Huang L (1996) Biodistribution of clodronate and liposomes used in the liposome mediated macrophage 'suicide' approach. Journal of immunological methods 192: 55-62.
37. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nature reviews Immunology 5: 953-964.
38. Solomon A, Richey T, Murphy CL, Weiss DT, Wall JS, et al. (2007) Amyloidogenic potential of foie gras. Proceedings of the National Academy of Sciences of the United States of America 104: 10998-11001.
39. Westermark P (2012) Localized AL amyloidosis: a suicidal neoplasm? Ups J Med Sci 117: 244-250.
40. Mambule C, Ando Y, Anan I, Holmgren G, Sandgren O, et al. (2000) Enhancement of AA-amyloid formation in mice by transthyretin amyloid fragments and polyethylene glycol. Biochimica et biophysica acta 1474: 331-336.
41. Engel MF, Khemtemourian L, Kleijer CC, Meeldijk HJ, Jacobs J, et al. (2008) Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane. Proceedings of the National Academy of Sciences of the United States of America 105: 6033-6038.
42. Milanesi L, Sheynis T, Xue WF, Orlova EV, Hellewell AL, et al. (2012) Direct three-dimensional visualization of membrane disruption by amyloid fibrils. Proceedings of the National Academy of Sciences of the United States of America 109: 20455-20460.
43. Van Rooijen N, Sanders A (1994) Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. Journal of immunological methods 174: 83-93.
44. Puchtler H, Sweat F (1965) Congo red as a stain for fluorescence microscopy of amyloid. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society 13: 693-694.